PCSK9 and atherosclerosis: A multi-target mRNA vaccination, for example, might promote endothelium repair and modulate inflammation in addition to reducing the metabolism of lipids (e.g., by encoding for PCSK9 inhibitors) to provide a holistic therapeutic approach against atherosclerosis.